![]() |
|
|
Vol. 11, Issue 10, 3365-3380, October 2000

and
*Department of Molecular Biophysics and Biochemistry, Yale
University, New Haven, Connecticut 06520; and
Department
of Biochemistry and Molecular Biology, University of Chicago, Chicago,
Illinois 60637
| |
ABSTRACT |
|---|
|
|
|---|
The Saccharomyces cerevisiae DOA4 gene encodes a deubiquitinating enzyme that is required for rapid degradation of ubiquitin-proteasome pathway substrates. Both genetic and biochemical data suggest that Doa4 acts in this pathway by facilitating ubiquitin recycling from ubiquitinated intermediates targeted to the proteasome. Here we describe the isolation of 12 spontaneous extragenic suppressors of the doa4-1 mutation; these involve seven different genes, six of which were cloned. Surprisingly, all of the cloned DID (Doa4-independent degradation) genes encode components of the vacuolar protein-sorting (Vps) pathway. In particular, all are class E Vps factors, which function in the maturation of a late endosome/prevacuolar compartment into multivesicular bodies that then fuse with the vacuole. Four of the six Did proteins are structurally related, suggesting an overlap in function. In wild-type and several vps strains, Doa4-green fluorescent protein displays a cytoplasmic/nuclear distribution. However, in cells lacking the Vps4/Did6 ATPase, a large fraction of Doa4-green fluorescent protein, like several other Vps factors, concentrates at the late endosome-like class E compartment adjacent to the vacuole. These results suggest an unanticipated connection between protein deubiquitination and endomembrane protein trafficking in which Doa4 acts at the late endosome/prevacuolar compartment to recover ubiquitin from ubiquitinated membrane proteins en route to the vacuole.
| |
INTRODUCTION |
|---|
|
|
|---|
Protein degradation plays an important part in numerous cellular
processes (Gottesman and Maurizi, 1992
). In eukaryotes, proteins that
must be rapidly destroyed are generally recognized and degraded by the
ubiquitin system (Hochstrasser, 1996
; Pickart, 1997
; Varshavsky, 1997
;
Ciechanover, 1998
). Attachment of ubiquitin to substrate proteins has
distinct mechanistic roles in two different intracellular proteolytic
pathways. For many short-lived cellular proteins, attachment to a
polyubiquitin chain(s) facilitates their binding to a large protease
called the 26S proteasome (Coux et al., 1996
; Pickart,
1997
). The ubiquitin molecules in these chains are linked by amide
bonds between Lys-48 of one ubiquitin and the C-terminal carboxyl group
of the next ubiquitin. After binding of the ubiquitin conjugate, the
proteasome degrades the substrate to small peptides. Many membrane
proteins are degraded by a different ubiquitin-dependent mechanism
(Hicke, 1997
; Bryant and Stevens, 1998
). Their attachment to either a
single ubiquitin or short Lys-63-linked ubiquitin oligomers appears to
trigger their endocytosis and/or transport through a series of
endosomal compartments to the vacuole/lysosome, where the proteins are
destroyed by vacuolar hydrolases (Roth and Davis, 1996
; Galan and
Haguenauer-Tsapis, 1997
; Kölling and Losko, 1997
; Levkowitz
et al., 1998
; Loayza and Michaelis, 1998
; Terrell et
al., 1998
).
Ubiquitin is a long-lived protein in the yeast
Saccharomyces cerevisiae, so it must be removed from
ubiquitin-substrate conjugates before or during substrate degradation
(Swaminathan et al., 1999
). In yeast, 17 deubiquitinating
enzymes (Dubs) are predicted from the completed genome sequence.
Several have been studied to a limited degree, but relatively little is
known about their physiological functions or natural substrates
(Wilkinson and Hochstrasser, 1998
). Among the most extensively
characterized Dubs is the yeast Doa4 enzyme, which has been shown to
play crucial roles in both ubiquitin-dependent proteolysis and
ubiquitin homeostasis (Papa and Hochstrasser, 1993
; Singer et
al., 1996
; Papa et al., 1999
; Swaminathan et
al., 1999
).
Doa4 appears to function late in the ubiquitin-proteasome pathway by
recycling ubiquitin from proteasome-targeted substrates. A significant
fraction of the enzyme is associated with 26S proteasomes, and
doa4 mutations interact genetically with mutations in
components of the proteasome. In exponentially growing cultures of
doa4 mutants, small ubiquitinated species accumulate; these
species were suggested to be the proteolytic remnants of ubiquitinated
proteins (Papa and Hochstrasser, 1993
; Papa et al., 1999
).
In addition, intracellular ubiquitin pools in the mutant become
depleted, particularly in stationary-phase cultures, as a result of the
proteolysis of ubiquitin itself. Partial suppression of ubiquitin
depletion by mutations in components of the 26S proteasome suggests
that this protease is at least partly responsible for the degradation
of ubiquitin (Swaminathan et al., 1999
). Conceivably, the
inability to release ubiquitin chains from proteasome-targeted
substrates leads to degradation of the entire ubiquitin-protein
conjugate. Such degradation may be inefficient, and the resulting
ubiquitin-peptide intermediates could accumulate on proteasomes,
thereby inhibiting overall rates of proteasomal degradation.
Recent studies of ubiquitin homeostasis in yeast led to the surprising
finding that inactivation of genes important for vacuolar proteolysis
and endocytosis significantly reduced ubiquitin depletion in
doa4 cells (Swaminathan et al., 1999
). These data
suggested that a substantial flux of cellular ubiquitin is involved in
endocytosis and vacuolar targeting of yeast membrane proteins and that
Doa4 has a direct or indirect role in this pathway as well. Here we provide evidence that the participation of Doa4 in this pathway is very
likely direct and appears to be at the late endosome/prevacuolar compartment (PVC) stage. We have identified suppressor mutations that
largely bypass the requirement for Doa4 in yeast cells; the mutants
were named Doa4-independent degradation or did mutants. Unexpectedly, all of the did mutations are in genes
important for the step in which the Golgi-to-vacuole and
endosome-to-vacuole protein trafficking pathways converge (Bryant and
Stevens, 1998
). On their own, the did mutations have little
or no effect on the proteolysis of several tested proteasome
substrates, but several of the did mutations lead to
substantial accumulation of cellular ubiquitin-protein conjugates. All
suppress the doa4 defects in proteasome substrate
degradation by a mechanism other than (or in addition to) restoring
cellular ubiquitin levels. These data suggest that the two major
intracellular proteolytic pathways
vacuolar and proteasomal
have in
common a requirement for protein deubiquitination by the Doa4 enzyme.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Strains and Materials
Yeast strains used in this study are listed in Table
1. The Escherichia
coli strains used were JM101 and WM1100. Yeast and bacterial
media were prepared as described, and standard yeast genetic and
recombinant DNA methods were used (Ausubel et al., 1989
).
Monoclonal mouse antibodies against the T7 and hemagglutinin (HA)
epitopes were purchased from Novagen (Madison, WI) and BAbCO (Richmond,
CA), respectively, and a mAb to ubiquitin was from D. Gottschling
(Hutchinson Cancer Research Center, Seattle, WA). Polyclonal rabbit
antibodies used were against ubiquitin (Swaminathan et al.,
1999
), Ste3 (Roth and Davis, 1996
) (from N. Davis, Wayne State
University, Detroit, MI), carboxypeptidase Y (CPY) (from A. Cooper,
University of Missouri, Kansas City, MO), and green fluorescent
protein (GFP; from P. Silver, Dana-Farber Cancer Center, Boston,
MA).
|
Isolation of did Mutants
The did1 to did5 mutants were originally
isolated during a screen for Schizosaccharomyces pombe
orthologues of the S. cerevisiae DOA4 gene (A.Y. Amerik. and
M. Hochstrasser, unpublished data) that was based on an X-gal plate
assay for enhanced Deg1-
gal degradation in the
doa4-1 mutant MHY11D5-8a (Papa and Hochstrasser, 1993
).
Seven plasmid-independent revertants were identified from ~70,000
colonies. Backcrossing revealed that the suppressor mutations were
unlinked to doa4-1, and suppression in all cases was
recessive. The mutants were sorted into five complementation groups
based on matings between different did doa4-1 double
mutants. When separated from the doa4-1 allele, all of the
mutants except did5-1 were found to have readily scored
recessive defects as well. During several unsuccessful attempts to
clone DID5 by suppression of Deg1-
gal
degradation in did5-1 doa4-1 cells, we also performed control transformations of the doa4-1 strain MHY1096 with an
empty vector. Five additional did suppressors unlinked to
doa4-1 were isolated, and suppression was also recessive.
Three of the suppressors were new did3 alleles based on
complementation by the cloned DID3 gene, and two,
did6-1 and did7-1, were in genes that did not
correspond to DID1-DID4. None of the cloned
DID genes on low-copy plasmids was able to reverse the
did5-1 doa4-1 suppressor phenotype.
The DID genes were cloned from either of two
CEN/URA3-based yeast genomic libraries, one made
in YCp50 (Rose et al., 1987
) and the other in YCplac33 (A.Y.
Amerik. and M. Hochstrasser, unpublished data). By means of a
plate-based selection, putative DID gene-containing clones
were identified by their ability to suppress the sensitivity of the
corresponding did single mutants to 0.8 µg/ml canavanine sulfate. To eliminate plasmid-independent revertants,
canavanine-resistant clones were streaked onto plates containing 5-FOA,
which is toxic to cells expressing the URA3 gene, to
identify cells that had lost the library plasmid. Plasmids from
transformants that were no longer canavanine-resistant after 5-FOA
treatment were recovered in E. coli and then retested in
mutant yeast cells. DNA subcloning was used to trace the complementing
activity from the original plasmid inserts to single ORFs except in the
case of DID2 (see below). Linkage of the six cloned genes
with the respective chromosomal did mutations was verified
by subcloning DID gene-containing DNA fragments into YIp352
(Hill et al., 1986
), directed integration of the resulting
plasmids into the yeast genome, and linkage analysis of the
YIp352-borne URA3 marker and the canavanine hypersensitivity caused by the did mutations.
To determine whether the DID2 ORF (YKR035w-A),
which was originally not annotated in the Saccharomyces
Genome Database (SGD), was expressed as protein, the ORF was fused at
its 5' end with a sequence encoding the T7-Tag epitope (Novagen). A
two-step PCR procedure was used for epitope tagging (Papa et
al., 1999
). PCR products were cloned in pGEM-T/Easy (Promega,
Madison, WI), excised with NotI, and subcloned into the
CEN/URA3 yeast-E. coli shuttle vector
pRS316 (Sikorski and Hieter, 1989
). The pRS316-T7-DID2 plasmid was
transformed into MHY1234 cells
(did2
::HIS3). Because the putative
DID2/YKR035w-A ORF was completely bracketed by
the YKR035c ORF on the opposite strand, selective
inactivation of DID2 was achieved by mutating the
presumptive DID2 start codon to an ATA codon. The mutation,
did2-3, did not alter the predicted protein sequence of
YKR035c. The next ATG in the DID2 ORF is codon 89, which if used to initiate translation would result in a truncated protein. The did2-3 allele was cloned into pRS316 as
described for the T7-Tag addition, and the allele was verified by DNA sequencing.
By DNA sequence analysis, we noticed that a sequence upstream of the predicted DID4/YKL002w ORF bore significant similarity to the 5' region of the DID3 ORF. Perfect matches to consensus 5' and 3' splice site and branch point sequences were found just upstream of the SGD-annotated YKL002w ORF, suggesting the presence of an intron. We verified this by PCR amplification from a cDNA library with the use of primers predicted to flank the intron position. Sequencing of the PCR fragment confirmed the absence of a 68-base pair (bp) DNA element that is in the genomic sequence and that corresponds to the predicted intron. The intron-encoding sequence spans nucleotides 437,476 to 437,543 in chromosome XI (SGD).
Yeast Strain and Plasmid Construction
To make deletion alleles of DID1, DID2, and DID3, the yeast HIS3 gene was amplified by PCR with the use of primers with 5' sequences that corresponded to the regions just upstream of the start codons and just downstream of the termination codons of the respective DID genes. The amplified fragments were used for transformation of MHY606 cells. The resulting heterozygous diploids were sporulated, and tetrads were dissected. His+ haploid segregants were checked by colony PCR. A two-step procedure was used to make a null allele of DID4. Fragments of 400 bp bearing the immediate 5' or 3' sequence flanking the DID4 ORF were amplified, as was a 1500-bp DNA fragment containing LEU2. The 5' sequences within the primers used to amplify LEU2 also corresponded to sequences immediately adjacent to the start and termination codons of DID4. In a second round of amplification, the overlapping LEU2 and DID4 flanking DNA fragments were annealed, extended by Taq polymerase, and then amplified with the use of the outermost DID4 primers. The resulting DNA fragment contained the LEU2 gene flanked by 400 bp of DID4 upstream and downstream sequences. After transformation of MHY606 with this PCR fragment, the diploid was sporulated and tetrads were dissected as described above.
Plasmids carrying vps27
::LEU2 and
vps45
::URA3 were obtained from
Robert Piper, University of Iowa, Iowa City, IA (Piper et
al., 1994
, 1995
). The inserts were transformed into yeast. Integration of the mutant alleles was verified by colony PCR, and
mutant segregants were identified by tetrad analysis. Yeast strains
with multiple gene deletions were made by the appropriate genetic
crosses. For high-copy expression of DID1-DID4,
the four genes were subcloned separately into the 2-µm vector
YEplac195 (Gietz and Sugino, 1988
). The resulting plasmids were
transformed into the various did
mutants.
Constructs for the expression of HA-tagged versions of Did1 and Did3
were generated by PCR amplification of the corresponding genes with the
use of primers matching the 5' and 3' ends of each ORF. SacI
and XhoI restriction sites were built into the 5' and 3'
primers, respectively, and PCR products were digested with SacI and XhoI and subcloned into the expression
vectors YATAG200 (CEN/ARS) and YRTAG310 (2 µm), which resulted in the
placement of the genes behind the CUP1 promoter and fused at
their 3' ends to a sequence encoding an in-frame HA epitope tag (see Li
and Hochstrasser, 1999
).
A DOA4-GFP gene fusion (S65T GFP variant) was made
previously for expression from a low-copy centromeric plasmid (F.R.
Papa and M. Hochstrasser, unpublished data). This fusion construct, which uses the DOA4 promoter, completely complemented the
canavanine sensitivity of the doa4
mutant. The insert DNA
encoding the Doa4-GFP protein was excised with HindIII and
KpnI and subcloned into YIp352. The resulting plasmid was
cleaved with BglII, which cuts at a unique site in
DOA4, to direct integration of the plasmid into the
chromosomal DOA4 locus in yeast strains SEY6210 and MBY11. Ura+ transformants were selected, and the site of
integration was verified by linkage analysis.
Anti-Ubiquitin Immunoblot Analysis
Anti-ubiquitin immunoblot analysis was done
essentially as described previously (Amerik et al., 1997
).
Cell were grown at 30°C to midlogarithmic phase, collected by
centrifugation, and resuspended in Laemmli gel-loading buffer. After
heating to 100°C for 10 min and spinning down cell debris, the
supernatants were loaded onto 16% Tricine-SDS-polyacrylamide gels
(Schägger and von Jagow, 1987
). Proteins were transferred to
Immobilon-P membranes (Millipore, Bedford, MA), and the blots were
boiled for 30 min in water before antibody incubations. Antibody
binding was detected with the use of ECL reagents (Amersham, Arlington
Heights, IL). Under the conditions used, the reactivity of free
ubiquitin was significantly weaker than that of ubiquitin-protein
conjugates, particularly with the mouse mAb.
Degradation Assays
Pulse-chase and pulse-labeling analyses were conducted as
described previously (Chen et al., 1993
). Cells were labeled
for 5-10 min with 35S-TransLabel (ICN
Pharmaceuticals, Costa Mesa, CA). Aliquots of yeast cells were
disrupted by mixing with an equal volume of 2% SDS, 90 mM HEPES, pH
7.5, and 30 mM DTT and heating at 100°C for 10 min. Cleared and
diluted cell extracts were precipitated with antibodies against
2
(Hochstrasser and Varshavsky, 1990
),
-galactosidase (Organon
Teknika, Malvern, PA), or T7-Tag (Novagen). To measure the degradation
of Ste3, 10 ml of cells was grown in minimal medium to
OD600 ~ 0.8, pelleted, and resuspended in 1 ml
of minimal medium. Cycloheximide was added to a final concentration 0.5 mg/ml. At the appropriate times, equal aliquots of cells were removed
and heated for 10 min at 100°C, and debris was removed by
centrifugation at 14,000 × g. Proteins were resolved
on 10% SDS-polyacrylamide gels and analyzed by anti-Ste3
immunoblot analysis with ECL detection.
Fluorescence Microscopy
Staining of yeast cell membranes with the FM 4-64 lipophilic dye
was performed as described previously with minor modifications (Vida
and Emr, 1995
). All strains were grown at 30°C in 10 ml of YPD to
OD600 ~ 1. Cells were harvested and resuspended
in 166 µl of YPD. FM 4-64 (0.4 µl of a 16 mM solution in DMSO) was
added to each tube and incubated at 30°C for 20 min. Cells were
harvested by centrifugation, resuspended in 0.2 ml of fresh YPD, and
incubated for 1 h at 30°C. Cells were collected by
centrifugation and resuspended in YPD, and a drop of the cell
suspension was placed on a slide and viewed by fluorescence microscopy.
Similar conditions were used to view GFP fusion proteins by intrinsic
GFP fluorescence.
Subcellular distributions of Did1, Did2, Did3, and Doa4 were examined
in fixed yeast strains by indirect immunofluorescence as described (Li
and Hochstrasser, 1999
). Formaldehyde was added to a final
concentration of 3.7% to exponentially growing cultures (10 ml). After
2 h, cells were centrifuged and washed with 10 ml of buffer B (0.1 M potassium phosphate, pH 6.8, 0.5 mM
MgCl2). Cells were collected by centrifugation,
washed with 10 ml of buffer C (0.1 M potassium
phosphate, pH 6.8, 0.5 mM
MgCl2, 1.2 M sorbitol), centrifuged, and
resuspended in 1 ml of buffer C. After addition of 5 µl of
-mercaptoethanol and 10 µl of zymolase 100T (Seikagaku America, Rockville, MD; 5 mg/ml in buffer C), cells were incubated at
30°C for 1 h, harvested, washed with 5 ml of buffer C, and resuspended in 1 ml of buffer C. Aliquots of cells (15 µl) were placed on polylysine-coated multiwell slides, incubated for 10 min, and
washed with 15 µl of PBS, pH 7. Cells were treated with 15 µl of
0.2% Triton X-100 in PBS for 10 min, washed three times with PBS, and
incubated in PBS containing 0.5% BSA for 10 min. Primary antibodies
were then added. After overnight incubation, cells were washed four
times with PBS and twice with PBS containing 0.5% BSA and then were
incubated for 1 h with secondary antibodies (Oregon Green goat
anti-mouse and Texas Red anti-rabbit immunoglobulin G conjugates;
Molecular Probes, Eugene, OR). After several washings with PBS and air
drying, mounting medium was added to each well, and slides were covered
with coverslips. Samples were viewed on a Zeiss (Thornwood, NY) LSM 510 confocal fluorescence microscope.
Analysis of CPY Sorting
Yeast cells were grown in 10 ml of minimal medium to OD600 ~ 1, harvested, and resuspended in 200 µl of zymolase buffer (50 mM Tris-HCl, pH 7.5, 10 mM MgCl2, 1 mM DTT, 1 M sorbitol) supplemented with yeast nitrogen base [YNB plus (NH4)2SO4], glucose, and amino acids. Zymolase 100T (10 µg/2 × 107 cells) was added, and the culture was incubated at 30°C for 1 h. Cells were washed twice in 1 ml of wash buffer (1 M sorbitol, 0.67% YNB, 2% glucose) and resuspended in 200 µl of labeling buffer (50 mM potassium phosphate, pH 7.4, 0.5% glucose, 1 M sorbitol). Twenty microliters of 35S-TransLabel was added, and cells were labeled at 30°C for 30 min, collected, and resuspended in chase buffer (0.67% YNB, 2% glucose, 10 mM methionine, 10 mM cysteine, 1 M sorbitol). After a 45-min chase period, cultures were centrifuged at 14,000 × g for 1 min to generate intracellular (pellet) and extracellular (supernatant) fractions. Levels of CPY in each fraction were determined by anti-CPY immunoprecipitation and quantified from data collected on a Storm 860 Phosphorimager (Molecular Dynamics) with the use of ImageQuant software.
| |
RESULTS |
|---|
|
|
|---|
Identification of doa4-1 Suppressors
Spontaneous suppressors of the doa4-1 mutation (Papa
and Hochstrasser, 1993
) were identified with the use of plate-based
screens for reversion of the defect in degradation of a normally
short-lived reporter protein, Deg1-
gal (see MATERIALS AND
METHODS). Deg1-
gal contains a degradation signal from the
Mat
2 transcriptional repressor but accumulates to abnormally high
levels in doa4 cells (Hochstrasser and Varshavsky,
1990
). Twelve recessive suppressors unlinked to the original
doa4-1 mutation were identified in two separate screens. The
mutants fell into seven different complementation groups (Table 2). Subsequently, we found that a
doa4
null allele was also efficiently suppressed by the
new mutations, indicating that they are bypass suppressors. Therefore,
the new mutations in these pseudorevertants were named Doa4-independent
degradation or did mutations.
|
To confirm that the reduced steady-state levels of
Deg1-
gal in the did doa4-1 double mutants
resulted from enhanced Deg1-
gal degradation, pulse-chase
analyses were performed (Figure 1). In all of the mutants except doa4-1 did5-1, the degradation
defect was nearly completely suppressed. In doa4-1 did5-1
cells, suppression was incomplete but still significant. As with many
mutants in the ubiquitin-proteasome pathway, the doa4-1
mutant is extremely sensitive to the arginine analogue canavanine and
grows poorly at high temperatures (Papa and Hochstrasser, 1993
). Both
of these defects were also partially suppressed in did
doa4-1 cells with the exception of did5-1 doa4-1
(Figure 2, A and C). Although the did mutations could partially suppress the doa4-1
canavanine and temperature sensitivities, the did single
mutants were themselves sensitive to these treatments if higher
concentrations of canavanine or higher growth temperatures were used
(Figure 2, B and D).
|
|
Isolation of the DID Genes
The DID1, DID2, DID3,
DID4, DID6, and DID7 genes were cloned
from yeast genomic DNA libraries by functional complementation of the
canavanine hypersensitivity of the corresponding yeast mutants (see
MATERIALS AND METHODS). DNA subcloning from the original genomic
inserts allowed identification of the genes responsible for the
complementing activity in each case except for DID2 (see below) (Table 2). Four of the DID genes were identified
previously from genetic screens unrelated to the present one.
DID1 is the same as SNF7/VPS32, which
encodes a protein involved in overcoming glucose repression of
transcription (Tu et al., 1993
) and in the trafficking of
proteins to the vacuole (Babst et al., 1998
).
DID3 is identical to VPS24, which was also
recently implicated in vacuolar protein sorting (Babst et
al., 1998
). Finally, DID6 and DID7 were found to be the same as VPS4 (Babst et al., 1997
)
and VPS27 (Piper et al., 1995
), respectively.
Both of these genes also encode proteins that participate in endosomal
transport. DID2 and DID4 encoded previously
uncharacterized proteins.
For DID2, the smallest complementing subclone included
two potential ORFs, YKR035c and YKR035w-A. The
latter sequence has similarity to other DID products (see
below) but is on the opposite strand from and completely bracketed by
the initially annotated YKR035c ORF. Because of this unusual
arrangement, we first wished to determine whether YKR035w-A
was in fact translated into protein. The YKR035w-A ORF was
fused at its 5' end with a sequence encoding a T7 epitope tag, and a
low-copy plasmid encoding the putative T7-tagged protein was
transformed into a did2 null mutant. Wild-type growth on
canavanine and at high temperature was restored, and a protein of the
predicted size was specifically immunoprecipitated (Figure
3A). To selectively inactivate
YKR035w-A without affecting the predicted protein sequence
of YKR035c, the initiation codon of the former ORF was
mutated to yield the did2-3 allele. The predicted protein,
if expressed, would be missing the first 88 residues of the wild-type
YKR035w-A protein. The did2-3 construct failed to complement
the canavanine hypersensitivity of a did2
strain (Figure
3B) or to prevent the suppression of Deg1-
gal degradation
in a did2-1 doa4-1 double mutant. We conclude that Did2 is encoded by YKR035w-A, a conclusion reinforced by the
sequence similarities discussed below.
|
Four of the DID Genes Encode Related Proteins
Unexpectedly, when the predicted Did proteins were compared, Did1,
Did2, Did3, and Did4 were found to be related in sequence (Figure
4A). All four are relatively small,
highly charged proteins that are predicted to be largely
-helical
and to have coiled-coil protein-interaction domains in their N-terminal
regions (Lupas et al., 1991
). All have acidic isoelectric
points, but they also all share a bias in charge distribution, with
basic residues concentrated in their N-terminal halves and acidic
residues in the C-terminal segments. These sequence and structural
similarities suggest that the Did1-Did4 proteins are related by
descent and may have comparable mechanisms of action.
|
Several genetic interactions between DID genes support this
last inference. When performing complementation analysis of the original did mutants, we noticed that the
did2-2/+ did4-1/+ double heterozygote was still
partially canavanine-sensitive, in contrast to the analogous double
heterozygote involving did2-1, which was fully
canavanine-resistant. This was true even though the did2-1 single mutant was slightly more sensitive to canavanine than was did2-2 (Figure 2B). Such allele-specific "unlinked
noncomplementation" is often an indication that the two encoded
proteins act in the same protein complex (Stearns and Botstein, 1988
).
We also placed each of the DID1-DID4 genes in
high-copy plasmids and determined whether any of them could suppress
the defects associated with a null allele of the other DID
genes. High-copy expression of DID4 suppressed the
temperature- and canavanine-sensitivity of did3
, but
cross-suppression was not observed in any other case. Did3 and Did4 are
the most closely related of the yeast proteins shown in Figure 4A,
sharing 30% identity and 57% similarity in a 161-residue overlap.
Although the yeast Did1-Did4 proteins were clearly related to
one another, much stronger similarities between individual yeast Did
proteins and proteins from other eukaryotes were evident (Figure 4).
The functional specialization of the Did proteins, therefore, appears
to have occurred early in eukaryotic evolution, and the high degree of
conservation (~40-50% identity) supports the importance of these
factors for normal cell function. We note several intriguing sequence
similarities between Did2 and Did4 and proteins from other organisms.
Did2, which is expressed from an ORF completely embedded in another
ORF, showed 47% identity with a previously overlooked predicted human
polypeptide (Figure 4B) that is also expressed from an ORF embedded in
another gene, in this case from an alternative reading frame on the
same strand as PRSM1 (Scott et al., 1996
).
PRSM1 is predicted to encode a secreted metalloprotease, and
a single mRNA is detected in a variety of cell types. The PRSM1 locus, which would include the DID2-like
sequence, is a candidate for a recently mapped breast cancer
susceptibility gene (Whitmore et al., 1998
) and for a
lymphedema-distichiasis gene (Mangion et al., 1999
), which
both mapped to chromosome 16q24.3. Did2 also displayed strong
similarity to DG1118, a Dictyostelium protein required for
normal morphological development (GenBank accession number 3789911).
Yeast Did4 was 45% identical (68% similar) to the human BC-2 protein,
a putative breast adenocarcinoma marker (Figure 4C). Thus, two of the
yeast Did proteins have human orthologues that may be altered in breast tumors.
Defects in Other Ubiquitin Pathway Components Are Not Suppressed by did Mutations
We tested whether did alleles could suppress mutations
in components of the ubiquitin-proteasome pathway other than Doa4. Double mutants involving did1 and did3 and
mutations in several well-characterized components of the ubiquitin
system were constructed through genetic crosses. The alleles used were
doa3-1, uba1-2, and ubp14
.
DOA3 encodes the essential
5 catalytic subunit of the 20S
proteasome (Chen and Hochstrasser, 1995
). Uba1 is an essential enzyme
responsible for the activation of ubiquitin (McGrath et al.,
1991
), and uba1-2 is a nonlethal hypomorphic allele (Swanson and Hochstrasser, 2000
). Ubp14 is a Dub that disassembles unanchored polyubiquitin chains and, like Doa4, is required for normal rates of
proteasomal degradation (Amerik et al., 1997
). No detectable suppression of the degradation defects associated with these mutations was found by pulse-chase analysis of several substrates. Moreover, growth of the double mutants was generally worse than for the single
mutants, most strikingly for uba1-2 did1
and
ubp14
did3
, which failed to form colonies
at 35 and 37°C, respectively. Therefore, suppression by the
did mutations was specific to doa4.
Suppression by did Mutations Is Substrate-Specific
To investigate the effects of did mutations in
doa4 cells on the proteolysis of substrates other than
Deg1-
gal, we measured the degradation of
2, Leu-
gal
and Ub-Pro
gal by pulse-chase analysis (Figure
5). The latter two proteins are
artificial test substrates that are ubiquitinated by distinct
mechanisms in vivo (Varshavsky, 1997
). We found that the
2
degradation defect was completely suppressed in all tested
doa4
did
double mutants. Leu-
gal, an
N-end rule substrate, was also degraded at close to wild-type rates in
doa4
did1
, doa4
did3
, and doa4
did4
cells,
but in the doa4
did2
strain, little if any
suppression was seen. Ub-Pro
gal remained long-lived in this latter
mutant as well, whereas in doa4
did1
,
doa4
did3
, and doa4
did4
cells, very weak suppression of the
doa4
Ub-Pro
gal degradation defect was observed.
Ub-Pro
gal degradation is known to be the most sensitive of the
tested substrates to perturbations of the ubiquitin-proteasome pathway
(Papa and Hochstrasser, 1993
; van Nocker et al., 1996
),
which would be consistent with a strong but partial bypass of the
doa4
proteolytic defect caused by mutation of the
DID genes. The inability of did2
but not other
did deletions to suppress the doa4
defect in
either Ub-Pro
gal or Leu-
gal degradation supports the idea that
the structurally related Did proteins make overlapping but distinct
contributions to ubiquitin-dependent processes mediated by Doa4.
|
Ubiquitin and Ubiquitin Conjugates in did and doa4 did Mutants
For some ubiquitin-proteasome pathway substrates, such as
Deg1-
gal and
2, the doa4 degradation defect
can be suppressed significantly by augmenting ubiquitin levels, which
become depleted in doa4 cells. In contrast, ubiquitin
overexpression results in little if any suppression of Leu-
gal and
Ub-Pro
gal degradation defects (Swaminathan et al., 1999
).
Hence, the turnover of some proteins in doa4 cells is
limited primarily by decreased ubiquitin availability, whereas for
other substrates, reduced proteolysis is caused by a distinct
doa4 defect(s). This latter defect is thought to arise from
impaired ubiquitin recycling from proteasome-targeted substrates (Papa
and Hochstrasser, 1993
; Papa et al., 1999
). Some of the
substrate-specific suppression effects noted above, therefore, might
reflect differences in the way the did mutations affect one
or the other of these doa4 molecular defects, e.g., they
might primarily increase cellular ubiquitin pools.
To investigate this idea, we examined ubiquitin and ubiquitin
conjugates in the various mutants by anti-ubiquitin
immunoblotting (Figure
6). In all of the doa4
did
double mutants, levels of free ubiquitin were
restored to wild-type levels or nearly so. Moreover, the intracellular
concentration of the signature low-molecular-mass ubiquitinated species
found in doa4 cells was greatly reduced in the double
mutants. For the strains that combined doa4
with did1
, did3
, or did4
, these
ubiquitinated species were present at very low concentrations. In the
doa4
did2
double mutant, the levels of the
small conjugates were slightly but reproducibly higher, a finding
congruent with the weaker proteolytic suppression by did2
(see above). Interestingly, both did
single and
doa4
did
double mutants accumulated a broad
array of higher-molecular-mass ubiquitin-protein conjugates, which
were difficult to distinguish from the species that accumulated in
proteasome mutants such as doa3-1 (Figure 6) (see DeMarini
et al., 1995
). This was clearest in the case of
did1
and doa4
did1
cells.
|
The did Mutants Are All Class E Vacuolar Protein-sorting Mutants
We had previously found a link between Doa4-regulated
ubiquitin homeostasis and the endocytic pathway in yeast (Swaminathan et al., 1999
). Moreover, four of the six mutants identified
in the present study, did1/vps32,
did3/vps24, did6/vps4, and
did7/vps27, had been identified as class E
vacuolar protein-sorting (vps) mutants (Piper et
al., 1995
; Babst et al., 1998
). These findings suggested a close connection between suppression of the doa4
proteolytic defect by inactivation of Did proteins and intracellular
protein trafficking. Mutations in VPS genes result in the
missorting of newly synthesized vacuolar proteins such as CPY to the
culture medium (Bryant and Stevens, 1998
). The VPS pathway merges with the endocytic pathway at a late endosome compartment also called the
PVC. Thus, proteins from both the trans-Golgi network and the plasma membrane are routed to the vacuole via this compartment. The
distinguishing feature of the subset of vps mutants called class E mutants is the accumulation in the perivacuolar region of
aberrant multilamellar structures known as the class E compartment, which is thought to be an exaggerated late endosome.
To determine whether Did2 and Did4 are also Vps proteins, CPY sorting
in the did2
and did4
mutants was analyzed
by pulse-chase experiments. Spheroplasts were radiolabeled with
35S-TransLabel and chased for 30 min in the
presence of excess unlabeled methionine and cysteine. CPY was
immunoprecipitated from intracellular and extracellular fractions, and
the immunoprecipitated proteins were separated by SDS-PAGE and
visualized by fluorography (Figure 7A).
After a 30-min chase in wild-type and doa4
cells, the
endoplasmic reticulum precursor form of CPY (p1) had been transported
to the Golgi, where the sugar chains were modified to yield the p2
precursor, and finally to the vacuole, where p2 was proteolytically
processed to mature enzyme (mCPY). In contrast, in all of the
did
mutants, a significant fraction of a p2-like CPY
isoform was secreted into the culture medium. Therefore,
did2 and did4 are vps mutants.
|
Vacuolar membranes and the class E compartment can be visualized
in living cells by incubation with the lipophilic fluorescent dye FM
4-64 (Vida and Emr, 1995
). In wild-type cells, the dye is taken up into
endosomal membranes and transported to the vacuolar membrane. In class
E vps mutants, the perivacuolar class E compartments are
prominently stained. Our experiments demonstrated that similar structures were also present in did2 and did4
mutants (Figure 7B). As another measure of class E Vps function, we
examined degradation of Ste3, the yeast
-factor receptor.
This protein is ubiquitinated at the plasma membrane, endocytosed, and
transported to the vacuole for degradation (Roth and Davis, 1996
).
Inactivation of vacuolar proteolysis by deletion of the PEP4
gene strongly stabilizes the receptor, whereas deletion of the class E
VPS2/REN1 gene also inhibits Ste3 degradation, but in this
case the effect is relatively moderate (Davis et al., 1993
).
Degradation of Ste3 in the did
mutants was analyzed by
following the disappearance of the receptor when protein translation
was blocked by adding cycloheximide to the medium and monitoring
protein by anti-Ste3 immunoblotting with
chemiluminescence detection. Based on this semiquantitative assay, Ste3
proteolysis was modestly impaired in all of the mutants tested (Figure
8). Thus, a partial block to the
degradation of endocytosed membrane proteins is likely a common
property of class E mutants. A more severe Ste3 degradation defect was
observed in doa4
cells, presumably as a result of
ubiquitin limitation, inasmuch as doa4
has the same
effect on the Ste2 receptor (Terrell et al., 1998
) and
uracil permease (Galan and Haguenauer-Tsapis, 1997
). Collectively,
these observations establish Did2 and Did4 as novel class E Vps
proteins.
|
Mutations in VPS Class C and Class D Genes Also Suppress doa4
To assess the consequences of perturbing other steps
in the secretory and VPS pathways on the doa4
degradation
defect, we constructed doa4
vps45
,
doa4
vps33
, and doa4
ypt1-A136D double mutants and measured
Deg1-
gal, Leu-
gal, and/or
2 degradation in these
cells. Vps45 belongs to the class D Vps proteins and is involved in
protein transport between the trans-Golgi network and the
PVC (Cowles et al., 1994
; Piper et al., 1994
),
whereas Vps33 is a class C Vps protein important for the final step of vacuolar protein sorting, the delivery of transport intermediates to
the vacuole (Banta et al., 1990
; Rieder and Emr, 1997
). Ypt1 is required for vesicle trafficking both from the endoplasmic reticulum
to the Golgi and within the Golgi complex (Jedd et al., 1995
). Deletion of VPS33 or VPS45 suppressed the
Deg1-
gal and Leu-
gal degradation defects of
doa4
cells (Figure 9A). In
contrast, the ypt1-A136D mutation, when introduced into
doa4
cells, did not change the rate of
Deg1-
gal or
2 degradation (Figure 9B). We also
attempted to test in doa4
cells the effect of introducing the sec4-8 mutation, which inhibits protein transport from
the trans-Golgi network to the plasma membrane (Salminen and
Novick, 1987
). However, sec4-8 appears to be lethal in
combination with doa4
, which might indicate a role for
the ubiquitin system in this part of the secretory pathway.
|
In summary, loss of Doa4 function can be at least partially overcome by
mutations that impair late steps of vacuolar protein sorting, i.e.,
transport of proteins to the late endosome or vacuole, but defects in
the protein secretion pathway may actually exacerbate doa4
defects.
Did2 and Doa4 Relocalize to a Class E-like Compartment in vps4/did6 Mutants
A subset of class E Vps factors, which are normally soluble and
found primarily in the cytoplasm, relocalize to the class E compartment
membrane in cells defective for the Vps4/Did6 ATPase (Babst et
al., 1998
). Specifically, Snf7/Vps32/Did1 and Vps24/Did3 relocalize, whereas Vps28 does not. Vps4 is thought to act as a
dissociation factor for a complex of class E proteins bound to the
cytoplasmic face of the late endosome. We confirmed that in
vps4
cells, Vps24/Did3 concentrated at the class E
compartment (Figure 10D). In addition,
we examined the localization of a T7 epitope-tagged Did2 protein in a
strain with a temperature-sensitive allele of vps4 at a
permissive temperature (24°C) or after a 45-min incubation at a
nonpermissive temperature (37°C) (Figure 10A). At 24°C, Did2
localized to numerous cytoplasmic dots, suggestive of small membranous
organelles, but after the shift to 37°C, Did2 was predominantly in
one to three large, bright-staining perivacuolar spots, which also
stained strongly with antibodies to CPY, a protein known to concentrate
in class E structures in vps4 cells (Babst et
al., 1998
). Therefore, Did2, like the structurally related Did1
and Did3 proteins, appears to associate reversibly with the late
endosome.
|
An analogous set of experiments was used to define the subcellular
distribution of Doa4. We constructed derivatives of wild-type and
vps4
strains that carried a chromosomally integrated DNA construct that expressed a functional fusion between Doa4 and the GFP
of Aequorea victoria (Chalfie et al., 1994
) and
examined the cells by scanning laser confocal microscopy (see MATERIALS AND METHODS). In wild-type cells, most of the Doa4-GFP fusion protein
was diffusely localized to the nucleus/cytoplasm. In cells expressing
Doa4-GFP from a centromeric plasmid, which increases levels of the
protein fusion, a similar distribution was observed but with a
relatively higher concentration in the nucleus. Strikingly, in the
vps4
mutant, a large fraction of the Doa4-GFP protein was found in one to three large spots located close to the vacuole (Figure 10C), even though Doa4-GFP expression was similar in the mutant and wild-type strains (Figure 10B). This effect was
vps4-specific: no relocalization of Doa4-GFP was observed
in did1
and did3
mutants. To confirm that
the bright Doa4-GFP foci represent class E compartments, cells
expressing both Doa4-GFP and Did3/Vps24-HA, a class E marker, were
costained with antibodies to the respective tags and examined by
immunofluorescence microscopy. The bright foci observed with the two
antibodies colocalized (Figure 10D). Thus, Doa4 localization in the
cell was controlled by Vps4/Did6 in a way that paralleled the
regulation of multiple class E factors by the ATPase, suggesting that
Doa4 could also function at the late endosome surface. It is important
to note that the doa4 mutant does not have an obvious
vps phenotype (Figure 7A), and Doa4 is evidently present at
levels below those of the Did/Vps class E proteins, based on the
relative difficulty of detecting it by a variety of methods. Therefore,
Doa4 is unlikely to function as a stoichiometric component of the late
endosome coat complex.
The accumulation of Doa4 in the class E compartment in
vps4
cells might require other class E factors. To test
this, we examined Doa4-GFP localization in did1
vps4
and did3
vps4
(Figure
10C) double mutants. In both cases, the bright Doa4-GFP foci were no longer observed (but based on FM 4-64 and anti-Vph1 staining, class E
compartments were present), suggesting that the protein complex formed
on the late endosome surface by specific class E factors is necessary
to recruit the Doa4 enzyme to these sites.
| |
DISCUSSION |
|---|
|
|
|---|
Here we have described a set of mutants in which the
doa4
defects in ubiquitin homeostasis and
proteasome-mediated proteolysis are efficiently overcome. All of the
corresponding cloned genes encode factors important for a specific step
in membrane trafficking to the vacuole. Most interestingly, the Doa4
deubiquitinating enzyme appears to localize reversibly with the late
endosome/PVC, along with a group of proteins essential for targeting of
membrane proteins to the vacuole. Doa4, therefore, may partition
dynamically between a soluble, at least partly proteasome-associated
pool (Papa et al., 1999
) and an endosomal membrane pool
(Figure 10). These results point to a previously unsuspected function
for the ubiquitin system in intracellular membrane protein trafficking and suggest that ubiquitinated membrane proteins can be deubiquitinated by Doa4 at the late endosome to recover ubiquitin and, possibly, to
control the fate of the tagged protein.
The Did Proteins
Strikingly, all six of the identified doa4
suppressor mutations inactivate class E Vps factors. Inactivation of
these proteins results in the accumulation of perivacuolar structures
consisting of stacked membrane cisternae (Rieder et al.,
1996
). This "class E compartment" is thought to represent an
exaggerated late endosome/PVC that accumulates because of the failure
of the late endosome to mature into a multivesicular body (MVB), which
would normally then fuse with the vacuole (Futter et al.,
1996
; Odorizzi et al., 1998
). The internal vesicles in MVBs
are enriched for specific lipids (Kobayashi et al., 1999
)
and for cell surface receptors destined for vacuolar/lysosomal
degradation (Futter et al., 1996
). Therefore, important
lipid- and protein-sorting steps must occur during the formation of MVBs.
Several results argue for confluent mechanistic roles for the Did
proteins in MVB maturation. First, four of the six Did proteins are
related in primary sequence. Second, genetic interactions are observed
among several of these factors, including nonallelic noncomplementation
and high-copy suppression. Third, four of the six Did proteins are
observed to concentrate in the class E compartment when another Did
protein, the Did6/Vps4 ATPase, is inactive, and ATPase-defective Vps4
proteins behave similarly (Babst et al., 1998
). These
hydrophilic and generally soluble factors are thought to form a
supramolecular complex on the surface of the late endosome/PVC that
drives or facilitates membrane invagination (Odorizzi et al., 1998
). Interestingly, Did1-Did4, Did6, and Did7 all have putative coiled-coil domains, and the coiled-coil region in Did6/Vps4 is known to be important for its localization to the PVC (Babst et al., 1998
). A potential coiled coil is also predicted
(Lupas et al., 1991
) in Doa4 (residues 683-704), which may
be necessary for its reversible association with Did/Vps coiled-coil proteins.
Strong sequence similarity is shared between the two novel class E Vps
factors identified in this study (Did2 and Did4) and two mammalian gene
products implicated in breast cancer (see RESULTS). TSG101, the likely
mammalian orthologue of another yeast class E Vps factor, Vps23/Stp22,
was originally identified as a tumor susceptibility gene (Li et
al., 1999
). These provocative findings suggest that proper MVB
maturation is critical for normal growth regulation in mammals. This
might result from a failure to down-regulate growth factor receptors
such as receptor protein tyrosine kinases. In yeast, several class E
vps mutants, including vps23, result in a failure
to degrade cell surface proteins (Figure 8), and in at least one case,
there is partial accumulation of receptors at the plasma membrane,
which was suggested to reflect either the recycling of receptors from a
late endosome (class E) compartment to the cell surface or a back-up
resulting from the downstream block (Davis et al., 1993
).
Doa4 and Intracellular Membrane Protein Trafficking
How might ubiquitin and Doa4 participate in these
internal membrane-sorting and rearrangement events? Many plasma
membrane proteins that are destined for degradation in the
vacuole/lysosome are ubiquitinated at the cell surface (Hicke, 1997
;
Bryant and Stevens, 1998
), and they may carry the ubiquitin tag at
least to the late endosome. Some intracellular membrane proteins
destined for the vacuole also might require ubiquitination even without passage through the plasma membrane (Beck et al., 1999
), a
fact that might be relevant to the suppression of doa4
by
vps45
, which is thought to act only in the
Golgi-to-vacuole pathway and not in the endocytic pathway (Piper
et al., 1994
). The ubiquitinated state of proteins at the
late endosome surface might help concentrate them in regions that will
invaginate and form the internal vesicles that eventually are delivered
to the vacuole interior, perhaps analogous to the function of protein
ubiquitination at the cell surface. In this regard, it is interesting
that Vps23 has an N-terminal domain related to E2 ubiquitin-conjugating
enzymes (but lacking the catalytic Cys residue) (Ponting et
al., 1997
). Thus, Vps23 might bind the ubiquitin moieties of
ubiquitinated membrane proteins and help cluster them on the late
endosome/PVC membrane. However, protein deubiquitination of these
proteins must generally occur before complete vesiculation and delivery
to the vacuole, because the cellular pool of ubiquitin is long-lived
(Swaminathan et al., 1999
). Based on the data presented
here, we propose that Doa4 is responsible for deubiquitination events
at the late endosome/PVC surface. Recruitment of the Doa4 enzyme to
this compartment appears to depend on Vps factors that assemble on the
late endosome and control MVB formation, which would help control the
timing and location of membrane protein deubiquitination.
Suppression of doa4
defects by the class C
vps33 mutant, which is thought to prevent the fusion of MVBs
with the vacuole, is more difficult to explain by the model described
above, i.e., this block would appear to be too late to allow rescue of
ubiquitin from modified membrane proteins. Several explanations can be
suggested. By analogy to the accumulation of cell surface receptors in
class E vps mutants (Davis et al., 1993
), there
might be a back-up in the VPS pathway caused by the class C mutant
block that slows PVC vesiculation. Alternatively, PVC membrane
involution and vesiculation might be reversible. A retrograde pathway
from the vacuole to the Golgi was recently shown to operate via the
late endosome/PVC (Bryant et al., 1998
). Interestingly,
transit from the PVC to the Golgi in this pathway does not depend on
Vps45, a class D factor. The suppression of doa4
by
vps45
might reflect a retrograde exit of ubiquitinated
membrane proteins from the PVC to the Golgi, where they may be
deubiquitinated by other Dubs, whereas anterograde rerouting of the
ubiquitinated proteins back to the PVC is blocked by loss of Vps45
(Beck et al., 1999
).
Recent results suggest the possibility of dynamic
ubiquitination/deubiquitination cycles along the endocytic pathway, and these events may help determine whether an endocytosed membrane protein
will continue toward the vacuole or be routed to another compartment.
In mammalian cells, ubiquitination of the EGF receptor appears to occur
at an endosomal compartment (Levkowitz et al., 1998
).
Components of the endocytic machinery itself may also be targets for
reversible ubiquitin additions. For example, Eps15, an endocytosis
factor that is required for ligand-induced EGF receptor uptake, is
ubiquitinated in response to EGF binding (van Delft et al.,
1997
), and genetic data strongly implicate the endocytosis factor
epsin, which binds Eps15, as a key target of the Drosophila fat facets deubiquitinating enzyme (Cadavid et al., 2000
).
The possibility of Dubs acting early in the endocytic pathway suggests a model for vps/did suppression of
doa4
(see below). It also raises the question of whether
in yeast there are also internal (re)ubiquitination events necessary
for trafficking to the vacuole. Conjugation to Lys-63-linked ubiquitin
oligomers enhances but is not absolutely necessary for the endocytosis
and degradation of certain membrane proteins (Galan and
Haguenauer-Tsapis, 1997
; Springael et al., 1999
). Free
Lys-63-linked chains are synthesized by the Ubc13 E2 isozyme, which
requires formation of a complex between Ubc13 and another E2-related
protein, Mms2, which, like Vps23, also lacks a catalytic Cys residue
(Hofmann and Pickart, 1999
). By analogy, Vps23, perhaps with Ubc13 or
Ubc4 (Arnason and Ellison, 1994
), might help (re)ubiquitinate endosomal
membrane proteins or extend their monoubiquitin additions, allowing
them to concentrate at PVC invagination sites, after which Doa4 is recruited to cleave off the ubiquitin tag. Unlike wild-type ubiquitin, supplementation of a doa4
strain with a ubiquitin-K63R
mutant fails to rescue many of its defects (Swaminathan et
al., 1999
).
Mechanisms of Suppression of doa4 Proteasomal Degradation Defects
A major question raised by the present work is how the
did/vps class E mutations suppress the majority
of the doa4
phenotypic aberrations, particularly its
defects in proteasomal degradation. As described previously, loss of
Doa4 can inhibit proteasomal degradation by several mechanisms
(Swaminathan et al., 1999
). A decrease in cellular ubiquitin
levels engendered by abnormal degradation of ubiquitin is sufficient to
account for the defect in degradation of some substrates, e.g., the
Mat
2 repressor. However, the defective degradation of other proteins
such as N-end rule substrates even when the mutant cells are
supplemented with extra ubiquitin indicates an additional point(s) of
inhibition. Although the did mutations restore ubiquitin to
normal or near-normal levels, most of them also suppress the defect in
N-end rule substrate proteolysis, which cannot be explained by the
increase in cellular ubiquitin. Conversely, the doa4
defect in Ub-Pro
gal degradation was not strongly suppressed by any
of the tested did
mutations, and N-end rule substrate
degradation was also not restored in did2
doa4
cells. Hence, whatever the bypass mechanism(s), it does not rescue proteasomal degradation completely in the
did
doa4
double mutants.
As a working hypothesis, we propose that the impairment of the VPS
and/or endocytic pathways in doa4
cells allows another deubiquitinating enzyme(s) to reach many of the targets normally acted
on by Doa4, including ubiquitinated proteasomal substrates and protein
remnants. The Did factors may normally sequester or otherwise
negatively regulate such a Dub. There is accumulating evidence for
multiple ubiquitination/deubiquitination steps along the endocytic
pathway (see above), and inhibition of deubiquitination at particular
points along the pathway may be needed to allow (re)ubiquitination of a
receptor target or endocytic factor, e.g., to allow formation of an
alternative ubiquitin structure such as a Lys-63-linked ubiquitin
oligomer. For instance, a Dub that is recruited earlier in the
endocytic pathway might normally be inactivated when specific Vps
factors assemble onto the membrane. Failure to form or recycle a normal
class E complex may result in release of the Dub such that it can act
on soluble ubiquitinated substrates and possibly even proteasome-bound
substrates. The model predicts that inactivation of the putative
endocytosis-associated Dub in a did
doa4
background will impair proteasome-mediated degradation, but this defect
should be reversed by provision of functional Doa4. A genetic screen to
test this and related predictions is being developed.
| |
ACKNOWLEDGMENTS |
|---|
We thank Antony Cooper, William Green, Dan Gottschling, and Pam Silver for antibodies and Rob Piper and Markus Babst for plasmids and strains. This work was supported by National Institutes of Health grant GM53756 and a Fletcher Scholar Award from the Cancer Research Foundation of Chicago to M.H.
| |
FOOTNOTES |
|---|
Corresponding author. E-mail address:
mark.hochstrasser{at}yale.edu.
| |
REFERENCES |
|---|
|
|
|---|
2 repressor.
Cell
74, 357-369[Medline].
2 repressor.
Cell
61, 697-708[Medline].This article has been cited by other articles:
![]() |
S. K. Shenoy, A. S. Modi, A. K. Shukla, K. Xiao, M. Berthouze, S. Ahn, K. D. Wilkinson, W. E. Miller, and R. J. Lefkowitz {beta}-Arrestin-dependent signaling and trafficking of 7-transmembrane receptors is reciprocally regulated by the deubiquitinase USP33 and the E3 ligase Mdm2 PNAS, April 21, 2009; 106(16): 6650 - 6655. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Weiss, S. Huppert, and R. Kolling ESCRT-III Protein Snf7 Mediates High-Level Expression of the SUC2 Gene via the Rim101 Pathway Eukaryot. Cell, November 1, 2008; 7(11): 1888 - 1894. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ren, N. Pashkova, S. Winistorfer, and R. C. Piper DOA1/UFD3 Plays a Role in Sorting Ubiquitinated Membrane Proteins into Multivesicular Bodies J. Biol. Chem., August 1, 2008; 283(31): 21599 - 21611. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Nakamura and S. Hirose Regulation of Mitochondrial Morphology by USP30, a Deubiquitinating Enzyme Present in the Mitochondrial Outer Membrane Mol. Biol. Cell, May 1, 2008; 19(5): 1903 - 1911. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Koulich, X. Li, and G. N. DeMartino Relative Structural and Functional Roles of Multiple Deubiquitylating Proteins Associated with Mammalian 26S Proteasome Mol. Biol. Cell, March 1, 2008; 19(3): 1072 - 1082. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Aragon, A. L. Rodriguez, O. Meirelles, S. Roy, G. S. Davidson, P. H. Tapia, C. Allen, R. Joe, D. Benn, and M. Werner-Washburne Characterization of Differentiated Quiescent and Nonquiescent Cells in Yeast Stationary-Phase Cultures Mol. Biol. Cell, March 1, 2008; 19(3): 1271 - 1280. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Rue, S. Mattei, S. Saksena, and S. D. Emr Novel Ist1-Did2 Complex Functions at a Late Step in Multivesicular Body Sorting Mol. Biol. Cell, February 1, 2008; 19(2): 475 - 484. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. Row, H. Liu, S. Hayes, R. Welchman, P. Charalabous, K. Hofmann, M. J. Clague, C. M. Sanderson, and S. Urbe The MIT Domain of UBPY Constitutes a CHMP Binding and Endosomal Localization Signal Required for Efficient Epidermal Growth Factor Receptor Degradation J. Biol. Chem., October 19, 2007; 282(42): 30929 - 30937. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zhang, M. Veselits, S. O'Neill, P. Hou, A. L. Reddi, I. Berlin, M. Ikeda, P. D. Nash, R. Longnecker, H. Band, et al. Ubiquitinylation of Igbeta Dictates the Endocytic Fate of the B Cell Antigen Receptor J. Immunol., October 1, 2007; 179(7): 4435 - 4443. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mollapour and P. W. Piper Hog1 Mitogen-Activated Protein Kinase Phosphorylation Targets the Yeast Fps1 Aquaglyceroporin for Endocytosis, Thereby Rendering Cells Resistant to Acetic Acid Mol. Cell. Biol., September 15, 2007; 27(18): 6446 - 6456. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jager, E. Gottwein, and H.-G. Krausslich Ubiquitination of Human Immunodeficiency Virus Type 1 Gag Is Highly Dependent on Gag Membrane Association J. Virol., September 1, 2007; 81(17): 9193 - 9201. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Iwaki, M. Onishi, M. Ikeuchi, A. Kita, R. Sugiura, Y. Giga-Hama, Y. Fukui, and K. Takegawa Essential roles of class E Vps proteins for sorting into multivesicular bodies in Schizosaccharomyces pombe Microbiology, August 1, 2007; 153(8): 2753 - 2764. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Nikko and B. Andre Split-Ubiquitin Two-Hybrid Assay To Analyze Protein-Protein Interactions at the Endosome: Application to Saccharomyces cerevisiae Bro1 Interacting with ESCRT Complexes, the Doa4 Ubiquitin Hydrolase, and the Rsp5 Ubiquitin Ligase Eukaryot. Cell, August 1, 2007; 6(8): 1266 - 1277. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Niendorf, A. Oksche, A. Kisser, J. Lohler, M. Prinz, H. Schorle, S. Feller, M. Lewitzky, I. Horak, and K.-P. Knobeloch Essential Role of Ubiquitin-Specific Protease 8 for Receptor Tyrosine Kinase Stability and Endocytic Trafficking In Vivo Mol. Cell. Biol., July 1, 2007; 27(13): 5029 - 5039. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Shenoy Seven-Transmembrane Receptors and Ubiquitination Circ. Res., April 27, 2007; 100(8): 1142 - 1154. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. M. Ma, E. Boucrot, J. Villen, E. B. Affar, S. P. Gygi, H. G. Gottlinger, and T. Kirchhausen Targeting of AMSH to Endosomes Is Required for Epidermal Growth Factor Receptor Degradation J. Biol. Chem., March 30, 2007; 282(13): 9805 - 9812. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Allen, T. A. Chernova, E. P. Tennant, K. D. Wilkinson, and Y. O. Chernoff Effects of Ubiquitin System Alterations on the Formation and Loss of a Yeast Prion J. Biol. Chem., February 2, 2007; 282(5): 3004 - 3013. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. J. Alwan and J. E. M. van Leeuwen UBPY-mediated Epidermal Growth Factor Receptor (EGFR) De-ubiquitination Promotes EGFR Degradation J. Biol. Chem., January 19, 2007; 282(3): 1658 - 1669. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zamborlini, Y. Usami, S. R. Radoshitzky, E. Popova, G. Palu, and H. Gottlinger Release of autoinhibition converts ESCRT-III components into potent inhibitors of HIV-1 budding PNAS, December 12, 2006; 103(50): 19140 - 19145. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Nickerson, M. West, and G. Odorizzi Correction 175, p. 715 J. Cell Biol., December 11, 2006; (2006) jcb.20060611320061128c. [Full Text] [PDF] |
||||
![]() |
G. V. Avvakumov, J. R. Walker, S. Xue, P. J. Finerty Jr., F. Mackenzie, E. M. Newman, and S. Dhe-Paganon Amino-terminal Dimerization, NRDP1-Rhodanese Interaction, and Inhibited Catalytic Domain Conformation of the Ubiquitin-specific Protease 8 (USP8) J. Biol. Chem., December 8, 2006; 281(49): 38061 - 38070. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Nickerson, M. West, and G. Odorizzi Did2 coordinates Vps4-mediated dissociation of ESCRT-III from endosomes J. Cell Biol., December 4, 2006; 175(5): 715 - 720. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Amerik, N. Sindhi, and M. Hochstrasser A conserved late endosome-targeting signal required for Doa4 deubiquitylating enzyme function J. Cell Biol., December 4, 2006; 175(5): 825 - 835. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kee, W. Munoz, N. Lyon, and J. M. Huibregtse The Deubiquitinating Enzyme Ubp2 Modulates Rsp5-dependent Lys63-linked Polyubiquitin Conjugates in Saccharomyces cerevisiae J. Biol. Chem., December 1, 2006; 281(48): 36724 - 36731. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Brace, L. P. Parkinson, and R. S. Fuller Skp1p Regulates Soi3p/Rav1p Association with Endosomal Membranes but Is Not Required for Vacuolar ATPase Assembly Eukaryot. Cell, December 1, 2006; 5(12): 2104 - 2113. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Auld, A. L. Hitchcock, H. K. Doherty, S. Frietze, L. S. Huang, and P. A. Silver The Conserved ATPase Get3/Arr4 Modulates the Activity of Membrane-Associated Proteins in Saccharomyces cerevisiae Genetics, September 1, 2006; 174(1): 215 - 227. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Agromayor and J. Martin-Serrano Interaction of AMSH with ESCRT-III and Deubiquitination of Endosomal Cargo J. Biol. Chem., August 11, 2006; 281(32): 23083 - 23091. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Canaan, X. Yu, C. J. Booth, J. Lian, I. Lazar, S. L. Gamfi, K. Castille, N. Kohya, Y. Nakayama, Y.-C. Liu, et al. FAT10/Diubiquitin-Like Protein-Deficient Mice Exhibit Minimal Phenotypic Differences. Mol. Cell. Biol., July 1, 2006; 26(13): 5180 - 5189. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rubio-Texeira and C. A. Kaiser Amino Acids Regulate Retrieval of the Yeast General Amino Acid Permease from the Vacuolar Targeting Pathway Mol. Biol. Cell, July 1, 2006; 17(7): 3031 - 3050. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Millard and S. A. Wood Riding the DUBway: regulation of protein trafficking by deubiquitylating enzymes J. Cell Biol., May 22, 2006; 173(4): 463 - 468. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. Row, I. A. Prior, J. McCullough, M. J. Clague, and S. Urbe The Ubiquitin Isopeptidase UBPY Regulates Endosomal Ubiquitin Dynamics and Is Essential for Receptor Down-regulation J. Biol. Chem., May 5, 2006; 281(18): 12618 - 12624. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Staub and D. Rotin Role of Ubiquitylation in Cellular Membrane Transport Physiol Rev, April 1, 2006; 86(2): 669 - 707. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Shim, C. Xiao, M. S. Hayden, K.-Y. Lee, E. S. Trombetta, M. Pypaert, A. Nara, T. Yoshimori, B. Wilm, H. Erdjument-Bromage, et al. CHMP5 is essential for late endosome function and down-regulation of receptor signaling during mouse embryogenesis. J. Cell Biol., March 27, 2006; 172(7): 1045 - 1056. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Breinig, T. Sendzik, K. Eisfeld, and M. J. Schmitt Dissecting toxin immunity in virus-infected killer yeast uncovers an intrinsic strategy of self-protection PNAS, March 7, 2006; 103(10): 3810 - 3815. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Boysen and A. P. Mitchell Control of Bro1-Domain Protein Rim20 Localization by External pH, ESCRT Machinery, and the Saccharomyces cerevisiae Rim101 Pathway Mol. Biol. Cell, March 1, 2006; 17(3): 1344 - 1353. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Azmi, B. Davies, C. Dimaano, J. Payne, D. Eckert, M. Babst, and D. J. Katzmann Recycling of ESCRTs by the AAA-ATPase Vps4 is regulated by a conserved VSL region in Vta1 J. Cell Biol., February 27, 2006; 172(5): 705 - 717. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Bowers, S. C. Piper, M. A. Edeling, S. R. Gray, D. J. Owen, P. J. Lehner, and J. P. Luzio Degradation of Endocytosed Epidermal Growth Factor and Virally Ubiquitinated Major Histocompatibility Complex Class I Is Independent of Mammalian ESCRTII J. Biol. Chem., February 24, 2006; 281(8): 5094 - 5105. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Mullally, T. Chernova, and K. D. Wilkinson Doa1 Is a Cdc48 Adapter That Possesses a Novel Ubiquitin Binding Domain Mol. Cell. Biol., February 1, 2006; 26(3): 822 - 830. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. K. Baxter, H. Abeliovich, X. Zhang, A. G. Stirling, A. L. Burlingame, and D. S. Goldfarb Atg19p Ubiquitination and the Cytoplasm to Vacuole Trafficking Pathway in Yeast J. Biol. Chem., November 25, 2005; 280(47): 39067 - 39076. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hayashi, T. Fukuzawa, H. Sorimachi, and T. Maeda Constitutive Activation of the pH-Responsive Rim101 Pathway in Yeast Mutants Defective in Late Steps of the MVB/ESCRT Pathway Mol. Cell. Biol., November 1, 2005; 25(21): 9478 - 9490. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Mizuno, T. Iura, A. Mukai, T. Yoshimori, N. Kitamura, and M. Komada Regulation of Epidermal Growth Factor Receptor Down-Regulation by UBPY-mediated Deubiquitination at Endosomes Mol. Biol. Cell, November 1, 2005; 16(11): 5163 - 5174. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tsacoumango, S. J. Kil, L. Ma, F. D. Sonnichsen, and C. Carlin A novel dileucine lysosomal-sorting-signal mediates intracellular EGF-receptor retention independently of protein ubiquitylation J. Cell Sci., September 1, 2005; 118(17): 3959 - 3971. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Rothfels, J. C. Tanny, E. Molnar, H. Friesen, C. Commisso, and J. Segall Components of the ESCRT Pathway, DFG16, and YGR122w Are Required for Rim101 To Act as a Corepressor with Nrg1 at the Negative Regulatory Element of the DIT1 Gene of Saccharomyces cerevisiae Mol. Cell. Biol., August 1, 2005; 25(15): 6772 - 6788. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. R. Jacquiau, R. C. A. M. van Waardenburg, R. J. D. Reid, M. H. Woo, H. Guo, E. S. Johnson, and M.-A. Bjornsti Defects in SUMO (Small Ubiquitin-related Modifier) Conjugation and Deconjugation Alter Cell Sensitivity to DNA Topoisomerase I-induced DNA Damage J. Biol. Chem., June 24, 2005; 280(25): 23566 - 23575. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Barwell, J. H. Boysen, W. Xu, and A. P. Mitchell Relationship of DFG16 to the Rim101p pH Response Pathway in Saccharomyces cerevisiae and Candida albicans Eukaryot. Cell, May 1, 2005; 4(5): 890 - 899. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Lin, L. A. Kimpler, T. V. Naismith, J. M. Lauer, and P. I. Hanson Interaction of the Mammalian Endosomal Sorting Complex Required for Transport (ESCRT) III Protein hSnf7-1 with Itself, Membranes, and the AAA+ ATPase SKD1 J. Biol. Chem., April 1, 2005; 280(13): 12799 - 12809. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Komada and N. Kitamura The Hrs/STAM Complex in the Downregulation of Receptor Tyrosine Kinases J. Biochem., January 1, 2005; 137(1): 1 - 8. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Xu, F. J. Smith Jr., R. Subaran, and A. P. Mitchell Multivesicular Body-ESCRT Components Function in pH Response Regulation in Saccharomyces cerevisiae and Candida albicans Mol. Biol. Cell, December 1, 2004; 15(12): 5528 - 5537. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wu, L. Yen, L. Irwin, C. Sweeney, and K. L. Carraway III Stabilization of the E3 Ubiquitin Ligase Nrdp1 by the Deubiquitinating Enzyme USP8 Mol. Cell. Biol., September 1, 2004; 24(17): 7748 - 7757. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bugnicourt, M. Froissard, K. Sereti, H. D. Ulrich, R. Haguenauer-Tsapis, and J.-M. Galan Antagonistic Roles of ESCRT and Vps Class C/HOPS Complexes in the Recycling of Yeast Membrane Proteins Mol. Biol. Cell, September 1, 2004; 15(9): 4203 - 4214. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Luhtala and G. Odorizzi Bro1 coordinates deubiquitination in the multivesicular body pathway by recruiting Doa4 to endosomes J. Cell Biol., August 30, 2004; 166(5): 717 - 729. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. McCullough, M. J. Clague, and S. Urbe AMSH is an endosome-associated ubiquitin isopeptidase J. Cell Biol., August 16, 2004; 166(4): 487 - 492. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Martin-Serrano, D. Perez-Caballero, and P. D. Bieniasz Context-Dependent Effects of L Domains and Ubiquitination on Viral Budding J. Virol., June 1, 2004; 78(11): 5554 - 5563. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Fiorani, R. J. D. Reid, A. Schepis, H. R. Jacquiau, H. Guo, P. Thimmaiah, P. Benedetti, and M.-A. Bjornsti The Deubiquitinating Enzyme Doa4p Protects Cells from DNA Topoisomerase I Poisons J. Biol. Chem., May 14, 2004; 279(20): 21271 - 21281. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Eguez, Y.-S. Chung, A. Kuchibhatla, M. Paidhungat, and S. Garrett Yeast Mn2+ Transporter, Smf1p, Is Regulated by Ubiquitin-Dependent Vacuolar Protein Sorting Genetics, May 1, 2004; 167(1): 107 - 117. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Z. Murray, L. A. Jolly, and S. A. Wood The FAM Deubiquitylating Enzyme Localizes to Multiple Points of Protein Trafficking in Epithelia, where It Associates with E-cadherin and {beta}-catenin Mol. Biol. Cell, April 1, 2004; 15(4): 1591 - 1599. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, A. Satoh, G. Warren, and H. H. Meyer VCIP135 acts as a deubiquitinating enzyme during p97-p47-mediated reassembly of mitotic Golgi fragments J. Cell Biol., March 29, 2004; 164(7): 973 - 978. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Shiflett, D. M. Ward, D. Huynh, M. B Vaughn, J. C. Simmons, and J. Kaplan Characterization of Vta1p, a Class E Vps Protein in Saccharomyces cerevisiae J. Biol. Chem., March 19, 2004; 279(12): 10982 - 10990. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Orlandi, M. Bettiga, L. Alberghina, and M. Vai Transcriptional Profiling of ubp10 Null Mutant Reveals Altered Subtelomeric Gene Expression and Insurgence of Oxidative Stress Response J. Biol. Chem., February 20, 2004; 279(8): 6414 - 6425. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-O. Blondel, J. Morvan, S. Dupre, D. Urban-Grimal, R. Haguenauer-Tsapis, and C. Volland Direct Sorting of the Yeast Uracil Permease to the Endosomal System Is Controlled by Uracil Binding and Rsp5p-dependent Ubiquitylation Mol. Biol. Cell, February 1, 2004; 15(2): 883 - 895. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Nikko, A.-M. Marini, and B. Andre Permease Recycling and Ubiquitination Status Reveal a Particular Role for Bro1 in the Multivesicular Body Pathway J. Biol. Chem., December 12, 2003; 278(50): 50732 - 50743. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Abe and H. Iida Pressure-Induced Differential Regulation of the Two Tryptophan Permeases Tat1 and Tat2 by Ubiquitin Ligase Rsp5 and Its Binding Proteins, Bul1 and Bul2 Mol. Cell. Biol., November 1, 2003; 23(21): 7566 - 7584. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. L. Yeo, L. Xu, J. Ren, V. J. Boulton, M. D. Wagle, C. Liu, G. Ren, P. Wong, R. Zahn, P. Sasajala, et al. Vps20p and Vta1p interact with Vps4p and function in multivesicular body sorting and endosomal transport in Saccharomyces cerevisiae J. Cell Sci., October 1, 2003; 116(19): 3957 - 3970. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. J. Alwan, E. J. J. van Zoelen, and J. E. M. van Leeuwen Ligand-induced Lysosomal Epidermal Growth Factor Receptor (EGFR) Degradation Is Preceded by Proteasome-dependent EGFR De-ubiquitination J. Biol. Chem., September 12, 2003; 278(37): 35781 - 35790. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Mizuno, K. Kawahata, M. Kato, N. Kitamura, and M. Komada STAM Proteins Bind Ubiquitinated Proteins on the Early Endosome via the VHS Domain and Ubiquitin-interacting Motif Mol. Biol. Cell, September 1, 2003; 14(9): 3675 - 3689. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Osaka, Y.-L. Wang, K. Takada, S. Takizawa, R. Setsuie, H. Li, Y. Sato, K. Nishikawa, Y.-J. Sun, M. Sakurai, et al. Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron Hum. Mol. Genet., August 15, 2003; 12(16): 1945 - 1958. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lee, S. Prakash, and A. Matouschek Concurrent Translocation of Multiple Polypeptide Chains through the Proteasomal Degradation Channel J. Biol. Chem., September 13, 2002; 277(38): 34760 - 34765. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Esch and B. Errede Pheromone induction promotes Ste11 degradation through a MAPK feedback and ubiquitin-dependent mechanism PNAS, July 9, 2002; 99(14): 9160 - 9165. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Bonangelino, E. M. Chavez, and J. S. Bonifacino Genomic Screen for Vacuolar Protein Sorting Genes in Saccharomyces cerevisiae Mol. Biol. Cell, July 1, 2002; 13(7): 2486 - 2501. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Bishop, A. Horman, and P. Woodman Mammalian class E vps proteins recognize ubiquitin and act in the removal of endosomal protein-ubiquitin conjugates J. Cell Biol., April 1, 2002; 157(1): 91 - 102. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Soetens, J.-O. De Craene, and B. Andre Ubiquitin Is Required for Sorting to the Vacuole of the Yeast General Amino Acid Permease, Gap1 J. Biol. Chem., November 16, 2001; 276(47): 43949 - 43957. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. van Kerkhof, C. M. A. dos Santos, M. Sachse, J. Klumperman, G. Bu, and G. J. Strous Proteasome Inhibitors Block a Late Step in Lysosomal Transport of Selected Membrane but not Soluble Proteins Mol. Biol. Cell, August 1, 2001; 12(8): 2556 - 2566. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Gong and A. Chang A mutant plasma membrane ATPase, Pma1-10, is defective in stability at the yeast cell surface PNAS, July 31, 2001; 98(16): 9104 - 9109. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dupre and R. Haguenauer-Tsapis Deubiquitination Step in the Endocytic Pathway of Yeast Plasma Membrane Proteins: Crucial Role of Doa4p Ubiquitin Isopeptidase Mol. Cell. Biol., July 15, 2001; 21(14): 4482 - 4494. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Horak and D. H. Wolf Glucose-Induced Monoubiquitination of the Saccharomyces cerevisiae Galactose Transporter Is Sufficient To Signal Its Internalization J. Bacteriol., May 15, 2001; 183(10): 3083 - 3088. [Abstract] [Full Text] |
||||
![]() |
G. Wang, J. M. McCaffery, B. Wendland, S. Dupré, R. Haguenauer-Tsapis, and J. M. Huibregtse Localization of the Rsp5p Ubiquitin-Protein Ligase at Multiple Sites within the Endocytic Pathway Mol. Cell. Biol., May 15, 2001; 21(10): 3564 - 3575. [Abstract] [Full Text] |
||||
![]() |
S. Losko, F. Kopp, A. Kranz, and R. Kölling Uptake of the ATP-Binding Cassette (ABC) Transporter Ste6 into the Yeast Vacuole Is Blocked in the doa4 Mutant Mol. Biol. Cell, April 1, 2001; 12(4): 1047 - 1059. [Abstract] [Full Text] |
||||
![]() |
T. L. Howard, D. R. Stauffer, C. R. Degnin, and S. M. Hollenberg CHMP1 functions as a member of a newly defined family of vesicle trafficking proteins J. Cell Sci., January 7, 2001; 114(13): 2395 - 2404. [Abstract] [Full Text] [PDF] |
||||
![]() |
N Matsuda, T Suzuki, K Tanaka, and A Nakano Rma1, a novel type of RING finger protein conserved from Arabidopsis to human, is a membrane-bound ubiquitin ligase J. Cell Sci., January 5, 2001; 114(10): 1949 - 1957. [Abstract] [PDF] |
||||
![]() |
T. Kamura, D. Burian, Q. Yan, S. L. Schmidt, W. S. Lane, E. Querido, P. E. Branton, A. Shilatifard, R. C. Conaway, and J. W. Conaway MUF1, A Novel Elongin BC-interacting Leucine-rich Repeat Protein That Can Assemble with Cul5 and Rbx1 to Reconstitute a Ubiquitin Ligase J. Biol. Chem., August 3, 2001; 276(32): 29748 - 29753. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Bishop, A. Horman, and P. Woodman Mammalian class E vps proteins recognize ubiquitin and act in the removal of endosomal protein-ubiquitin conjugates J. Cell Biol., April 1, 2002; 157(1): 91 - 102. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||